Stryker (NYSE: SYK)
Key Data Points
Stryker Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Stryker Company Info
Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
News & Analysis
Is This MedTech Giant a Buy for Dividend Investors?
The company stands out as a titan of the medical devices industry.
This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?
The medical devices company announced a payout hike earlier this year.
2 Healthcare Stocks That Could Help Set You Up for Life
Healthcare is a critically important economic sector.
Which Is the Safer Dividend Stock: Stryker or Medtronic?
Both are on the safer side, but one is increasing its dividend payout a bit faster.
Should Investors Buy This Dividend Growth Stock?
This medical devices company is already up in 2023. Should you buy it?
Is This Dividend Growth Stock a Buy?
The medical devices giant has outperformed the S&P 500 index so far in 2022.
2 Top Healthcare Stocks to Buy Right Now
A growing and aging global population serves as a major tailwind for the healthcare sector.
2 Under-the-Radar Medtech Stocks to Buy Now
Don't count out these discounted medical technology stocks.
Financial Health
General
Q4 2024 | YoY Change |
---|
Revenue Growth Rate
Earnings Per Share Growth Rate
Assets
Q4 2024 | YoY Change |
---|
Liabilities
Q4 2024 | YoY Change |
---|
Ratios
Q4 2024 | YoY Change |
---|
Cash Flow
Q4 2024 | YoY Change |
---|
Valuation
Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | YoY Change |
---|
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.